Skip to main navigation Skip to search Skip to main content

A Randomized Phase 3 Study of Pemetrexed in Combination with Cisplatin Versus Cisplatin Monotherapy in Patients with Recurrent or Metastatic Head and Neck Cancer

Project: Research

Project Details

StatusFinished
Effective start/end date09/4/0810/13/12

Funding

  • Eli Lilly and Company: $11,946.16